Summary of Cedars-Sinai Investigation Shows Increased Diabetes Risk:
COVID-19 survivors have an increased risk of developing new-onset Type 2 diabetes, which contributes significantly to cardiovascular disease, according to new research from the Smidt Heart Institute at Cedars-Sinai. The study evaluated over 23,000 adult patients and found that the combined risk of Type 2 diabetes after COVID-19 exposure was 2.1%, with 70% occurring after infection. The trouble was bigger in unvaccinated patients (2.7%) than in vaccinated patients (1.0%). The findings suggest that COVID-19 vaccination before illness may protect against diabetes risk. The research indicates that diabetes risk persists across COVID-19 variants, and upfront vaccination may help to reduce the risk of post-infection diabetes.
*****
COVID-19 Survivors at Increased Risk of New-Onset Type 2 Diabetes, Says Study
Researchers from the Smidt Heart Institute at Cedars-Sinai have uncovered a concerning link between COVID-19 survivors and new-onset Type 2 diabetes. According to the study, COVID-19 survivors face a 2.1% risk of developing Type 2 diabetes, with 70% occurring after infection. The trouble is more significant in unvaccinated patients, at 2.7%, than in vaccinated patients, at 1.0%. The findings suggest that COVID-19 vaccination before illness may protect against diabetes risk. Moreover, the results indicate that upfront vaccination may help to reduce the risk of post-infection diabetes.
Persisting Risk Across COVID-19 Variants
The risk of Type 2 diabetes was found to persist across COVID-19 variants, according to the study. Even as new variants continue to emerge, there remains a consistent link between COVID-19 infection and diabetes risk, underscoring the importance of early vaccination against the virus. As per the study’s authors, this study helps to understand and better prepare for the post-COVID-19 era of cardiovascular risk.
Diabetes Risk Amplified by COVID-19?
Early diagnosis and treatment of diabetes are vital to preventing cardiovascular disease and other complications. “We remain steadfast in our belief that COVID-19 vaccination remains an important tool in protecting against COVID-19 and the still-uncertain risks that people may experience during the post-infection period,” Alan Kwan, MD, a cardiovascular physician in the Smidt Heart Institute at Cedars-Sinai, said. Study senior author Susan Cheng, MD, MPH, noted that the findings suggest COVID-19 infection could act as a “disease accelerator, amplifying risk for a diagnosis that individuals might have otherwise received later in life.”
Ultimate Goal: Keeping People Healthy
“Our ultimate goal—with every research study we conduct—is to find ways to keep people healthy and able to engage in their everyday activities and lives,” Kwan said. This research is one piece of the puzzle that will help researchers understand how to prevent future metabolic and cardiovascular disease risks. The study’s findings underscore the importance of early vaccination against COVID-19 and highlight the need for ongoing research on the correlation between COVID-19 and diabetes risk. Ultimately, it is essential to stay vigilant and take proper measures to prevent the spread of the virus.
Conclusion
The link between COVID-19 survivors and new-onset Type 2 diabetes underlines the importance of early vaccination and awareness of the possible post-infection risks. The study’s findings suggest that COVID-19 vaccination before infection may provide a protective effect against diabetes chance, which highlights the need for widespread vaccination campaigns. This research also sheds light on the long-term impact of COVID-19 on the body, opening new avenues for inquiry into the aftereffects of the virus. We must remain informed and take precautions against COVID-19 to protect ourselves and our communities.
Comments are closed